Arrowhead Pharmaceuticals Inc (ARWR)

48.83 +4.32  +9.71% NASDAQ Jul 13, 13:47 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/25/2020 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2020
11/25/2020 Earnings Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings for 2020 Release
08/05/2020 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call for 2020
08/05/2020 Earnings Arrowhead Pharmaceuticals Inc Third Quarter Earnings Result for 2020
05/07/2020 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2020
05/07/2020 Earnings Arrowhead Pharmaceuticals Inc Second Quarter Earnings Result for 2020
03/19/2020 10:00 PDT Misc Arrowhead Pharmaceuticals Inc Annual General Meeting for 2019
02/05/2020 16:30 EST Misc Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call for 2020
02/05/2020 Earnings Arrowhead Pharmaceuticals Inc First Quarter Earnings in 2020 Release
11/25/2019 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.arrowheadpharma.com
  • Investor Relations URL: http://ir.arrowheadpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 05, 2020
  • Last Earnings Release: May. 07, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Top Fund Holders

Symbol Name Weighting
F000013RUT FT Sabrient Small Cap Growth 23 F RE 4.94%
GNOM Global X Genomics & Biotechnology ETF 3.77%
CUVAVX GUGG Undervalued Top Picks 22 RE 3.45%
SBIO ALPS Medical Breakthroughs ETF 3.23%
APSRX Fiera Capital Small/Mid-Cap Growth Inv 1.88%
IMPAX ERShares US Small Cap Fund™ Inst 1.88%
GOFFX Invesco Oppenheimer Global Opp R5 1.59%
XBI SPDR® S&P Biotech ETF 1.31%
QSSRX AQR TM Small Cap Multi-Style R6 0.74%
SMLF iShares Edge MSCI Mltfct USA SmCp ETF 0.70%
IWO iShares Russell 2000 Growth ETF 0.50%
IWM iShares Russell 2000 ETF 0.26%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.